Genetic and environmental influences on LDL subclass phenotypes

There is accumulating evidence that subclasses of low‐density lipoproteins (LDL) are important in atherosclerosis. Several case‐control studies have demonstrated that a predominance of small, dense LDL (LDL subclass phenotype B) is associated with increased risk of coronary heart disease (CHD). Phenotype B is also consistently characterized by an atherogenic lipoprotein phenotype, including increased levels of plasma triglyceride and decreased high‐density lipoprotein cholesterol. Family studies and genetic linkage studies demonstrate that LDL subclasses are influenced by a single major gene effect, although this locus (or loci) remain to be definitively mapped. Twin studies confirm the presence of genetic effects, but also show that non‐genetic influences are important. Hypolipidemic drugs, beta‐blockers, diet and exercise, in particular, appear to influence the expression of LDL subclass phenotypes. This combination of genetic and environmental influences may provide opportunities to develop targeted intervention strategies to reduce CHD risk among genetically susceptible individuals.

[1]  R. Krauss,et al.  Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. , 1992, Atherosclerosis.

[2]  J. Hendriks,et al.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  W. Willett,et al.  Nutrient intake comparisons between Framingham and rural and Urban Puriscal, Costa Rica. Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  M. King,et al.  Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. , 1988, American journal of human genetics.

[5]  C. Packard,et al.  Effects of simvastatin on apoB metabolism and LDL subfraction distribution. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  D. Swinkels,et al.  Both inherited susceptibility and environmental exposure determine the low-density lipoprotein-subfraction pattern distribution in healthy Dutch families. , 1992, American journal of human genetics.

[7]  D. Steinberg,et al.  Role of oxidised low density lipoprotein in atherogenesis. , 1993, British heart journal.

[8]  V. Vaccarino,et al.  Plasma lipoprotein changes after treatment with pravastatin and gemfibrozil in patients with familial hypercholesterolemia. , 1989, The Journal of laboratory and clinical medicine.

[9]  R. Krauss,et al.  Detection and quantitation of LDL subfractions , 1992 .

[10]  M. Austin Genetics of low-density lipoprotein subclasses , 1993 .

[11]  A. Hamsten,et al.  Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. , 1991, Atherosclerosis.

[12]  E. Bruckert,et al.  Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. , 1993, Journal of lipid research.

[13]  R. Krauss,et al.  LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women , 1993, Circulation.

[14]  P. Wilson,et al.  LDL particle size distribution. Results from the Framingham Offspring Study. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  P. Wilson,et al.  The NHLBI Twin Study: heritability of apolipoprotein A-I, B, and low density lipoprotein subclasses and concordance for lipoprotein(a). , 1991, Atherosclerosis.

[16]  R. Krauss,et al.  Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[17]  R. Krauss,et al.  Differential effects of nicotinic acid in subjects with different LDL subclass patterns. , 1992, Atherosclerosis.

[18]  P. Wilson,et al.  Change in LDL particle size is associated with change in plasma triglyceride concentration. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[19]  R. Krauss,et al.  Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Wilson,et al.  Low density lipoprotein particle size and coronary artery disease. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  M. Austin,et al.  Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. , 1993, Atherosclerosis.

[22]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[23]  R. Krauss,et al.  Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. , 1990, Arteriosclerosis.

[24]  R. Krauss,et al.  Lipoprotein subfractions of runners and sedentary men. , 1986, Metabolism: clinical and experimental.

[25]  R. Krauss,et al.  Linkage analysis of low‐density lipoprotein subclass phenotypes and the apolipoprotein B gene , 1991, Genetic epidemiology.

[26]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[27]  D. Hunninghake,et al.  Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans. , 1991, Atherosclerosis.

[28]  J. Maccluer Biometrical studies to detect new genes with major effects on quantitative risk factors for atherosclerosis , 1992 .

[29]  R. Krauss,et al.  Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. , 1990, Circulation.

[30]  M. King,et al.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. , 1990, Circulation.

[31]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[32]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[33]  E. Wijsman,et al.  Lack of evidence for linkage between low‐density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia , 1991, Genetic epidemiology.

[34]  R. Krauss,et al.  Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. , 1989, Arteriosclerosis.

[35]  J. Hokanson,et al.  Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  A. Van der Laarse,et al.  Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[37]  D. Hunninghake,et al.  Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies. , 1992, Atherosclerosis.